Oramed Pharmaceuticals Inc. (ORMP) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Oramed Pharmaceuticals In...

    NASDAQ: ORMP · Real-Time Price · USD
    2.40
    0.00 (0.00%)
    At close: Sep 26, 2025, 1:15 PM

    Oramed Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Aug 31, 2021
    Revenue
    		 n/a 1.34M 2.7M 2.7M
    Cost of Revenue
    		 193K n/a n/a n/a
    Gross Profit
    		 -193K 1.34M 2.7M 2.7M
    Operating Income
    		 -12.78M -15.77M -40.6M -24.22M
    Interest Income
    		 n/a 8.03M 3.57M 347K
    Pretax Income
    		 -15.92M 5.09M -37.66M -22.99M
    Net Income
    		 -19.1M 5.53M -37.76M -22.24M
    Selling & General & Admin
    		 6.46M 8.14M 15.66M 5.94M
    Research & Development
    		 6.32M 8.97M 27.64M 20.99M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 12.78M 17.11M 43.3M 26.93M
    Interest Expense
    		 853K 3.58M n/a 6K
    Selling & Marketing Expenses
    		 n/a -287K 1.85M n/a
    Cost & Expenses
    		 12.78M 17.11M 43.3M 26.93M
    Income Tax Expense
    		 3.18M n/a 100K -2.88M
    Shares Outstanding (Basic)
    		 40.83M 40.32M 39M 28.47M
    Shares Outstanding (Diluted)
    		 40.83M 40.57M 39M 28.47M
    EPS (Basic)
    		 -0.47 0.14 -0.97 -0.78
    EPS (Diluted)
    		 -0.47 0.14 -0.97 -0.78
    EBITDA
    		 -14.87M -15.57M -36.98M -25.04M
    EBIT
    		 -15.07M 7.13M -40.6M n/a
    Depreciation & Amortization
    		 193K 196K 3.62M 77K

    Add to Watchlist